| Record Information |
|---|
| Version | 5.0 |
|---|
| Status | Expected but not Quantified |
|---|
| Creation Date | 2017-09-09 02:51:28 UTC |
|---|
| Update Date | 2022-11-30 19:25:56 UTC |
|---|
| HMDB ID | HMDB0114841 |
|---|
| Secondary Accession Numbers | None |
|---|
| Metabolite Identification |
|---|
| Common Name | PA(16:0/20:4(5Z,8Z,11Z,14Z)) |
|---|
| Description | PA(16:0/20:4(5Z,8Z,11Z,14Z)) is a phosphatidic acid. It is a glycerophospholipid in which a phosphate moiety occupies a glycerol substitution site. As is the case with diacylglycerols, phosphatidic acids can have many different combinations of fatty acids of varying lengths and saturation attached at the C-1 and C-2 positions. Fatty acids containing 16, 18 and 20 carbons are the most common. PA(16:0/20:4(5Z,8Z,11Z,14Z)), in particular, consists of one chain of palmitic acid at the C-1 position and one chain of arachidonic acid at the C-2 position. Phosphatidic acids are quite rare but are extremely important as intermediates in the biosynthesis of triacylglycerols and phospholipids. |
|---|
| Structure | [H][C@@](COC(=O)CCCCCCCCCCCCCCC)(COP(O)(O)=O)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC InChI=1S/C39H69O8P/c1-3-5-7-9-11-13-15-17-18-19-20-22-24-26-28-30-32-34-39(41)47-37(36-46-48(42,43)44)35-45-38(40)33-31-29-27-25-23-21-16-14-12-10-8-6-4-2/h11,13,17-18,20,22,26,28,37H,3-10,12,14-16,19,21,23-25,27,29-36H2,1-2H3,(H2,42,43,44)/b13-11-,18-17-,22-20-,28-26-/t37-/m1/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| 1-Hexadecanoyl-2-(5Z,8Z,11Z,14Z-icosatetraenoyl)-sn-glycero-3-phosphate | ChEBI | | 1-Palmitoyl-2-arachidonoyl-sn-glycerol 3-phosphate | ChEBI | | 2-Arachidonoyl-1-palmitoyl-sn-glycero-3-phosphate | ChEBI | | PA(16:0/20:4) | ChEBI | | 1-Hexadecanoyl-2-(5Z,8Z,11Z,14Z-icosatetraenoyl)-sn-glycero-3-phosphoric acid | Generator | | 1-Palmitoyl-2-arachidonoyl-sn-glycerol 3-phosphoric acid | Generator | | 2-Arachidonoyl-1-palmitoyl-sn-glycero-3-phosphoric acid | Generator | | 1-Palmitoyl-2-arachidonoyl-sn-glycero-3-phosphate | HMDB | | 1-Palmitoyl-2-arachidonoyl-sn-phosphatidic acid | HMDB | | PA(16:0/20:4N6) | HMDB | | PA(16:0/20:4W6) | HMDB | | PA(36:4) | HMDB | | Phosphatidic acid(16:0/20:4(5Z,8Z,11Z,14Z)) | HMDB | | Phosphatidic acid(16:0/20:4) | HMDB | | Phosphatidic acid(16:0/20:4n6) | HMDB | | Phosphatidic acid(16:0/20:4W6) | HMDB | | Phosphatidic acid(36:4) | HMDB | | Phosphatidate(16:0/20:4(5Z,8Z,11Z,14Z)) | HMDB | | Phosphatidate(16:0/20:4) | HMDB | | Phosphatidate(16:0/20:4N6) | HMDB | | Phosphatidate(16:0/20:4W6) | HMDB | | Phosphatidate(36:4) | HMDB | | 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphate | SMPDB, HMDB | | 1-palmitoyl-2-arachidonoyl-sn-phosphatidic acid | SMPDB, HMDB | | PA(16:0/20:4) | SMPDB, ChEBI | | PA(16:0/20:4n6) | SMPDB, HMDB | | PA(16:0/20:4w6) | SMPDB, HMDB | | PA(36:4) | SMPDB, HMDB | | Phosphatidic acid(16:0/20:4(5Z,8Z,11Z,14Z)) | SMPDB, HMDB | | Phosphatidic acid(16:0/20:4) | SMPDB, HMDB | | Phosphatidic acid(16:0/20:4n6) | SMPDB, HMDB | | Phosphatidic acid(16:0/20:4w6) | SMPDB, HMDB | | Phosphatidic acid(36:4) | SMPDB, HMDB | | Phosphatidate(16:0/20:4(5Z,8Z,11Z,14Z)) | SMPDB, HMDB | | Phosphatidate(16:0/20:4) | SMPDB, HMDB | | Phosphatidate(16:0/20:4n6) | SMPDB, HMDB | | Phosphatidate(16:0/20:4w6) | SMPDB, HMDB | | PA(16:0/20:4(5Z,8Z,11Z,14Z)) | SMPDB |
|
|---|
| Chemical Formula | C39H69O8P |
|---|
| Average Molecular Weight | 696.947 |
|---|
| Monoisotopic Molecular Weight | 696.47300618 |
|---|
| IUPAC Name | [(2R)-3-(hexadecanoyloxy)-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]propoxy]phosphonic acid |
|---|
| Traditional Name | (2R)-3-(hexadecanoyloxy)-2-[(5Z,8Z,11Z,14Z)-icosa-5,8,11,14-tetraenoyloxy]propoxyphosphonic acid |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | [H][C@@](COC(=O)CCCCCCCCCCCCCCC)(COP(O)(O)=O)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC |
|---|
| InChI Identifier | InChI=1S/C39H69O8P/c1-3-5-7-9-11-13-15-17-18-19-20-22-24-26-28-30-32-34-39(41)47-37(36-46-48(42,43)44)35-45-38(40)33-31-29-27-25-23-21-16-14-12-10-8-6-4-2/h11,13,17-18,20,22,26,28,37H,3-10,12,14-16,19,21,23-25,27,29-36H2,1-2H3,(H2,42,43,44)/b13-11-,18-17-,22-20-,28-26-/t37-/m1/s1 |
|---|
| InChI Key | SPYWWYSOADUXOQ-YABMZCMSSA-N |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as 1,2-diacylglycerol-3-phosphates. These are glycerol-3-phosphates in which the glycerol moiety is bonded to two aliphatic chains through ester linkages. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Lipids and lipid-like molecules |
|---|
| Class | Glycerophospholipids |
|---|
| Sub Class | Glycerophosphates |
|---|
| Direct Parent | 1,2-diacylglycerol-3-phosphates |
|---|
| Alternative Parents | |
|---|
| Substituents | - 1,2-diacylglycerol-3-phosphate
- Fatty acid ester
- Monoalkyl phosphate
- Dicarboxylic acid or derivatives
- Fatty acyl
- Alkyl phosphate
- Phosphoric acid ester
- Organic phosphoric acid derivative
- Carboxylic acid ester
- Carboxylic acid derivative
- Hydrocarbon derivative
- Organic oxide
- Organic oxygen compound
- Carbonyl group
- Organooxygen compound
- Aliphatic acyclic compound
|
|---|
| Molecular Framework | Aliphatic acyclic compounds |
|---|
| External Descriptors | |
|---|
| Ontology |
|---|
| Physiological effect | Not Available |
|---|
| Disposition | |
|---|
| Process | Naturally occurring processBiological processBiochemical pathwayMetabolic pathway- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/22:0) (PathBank: SMP0065397)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/16:1(9Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0068759)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/18:0/16:0) (PathBank: SMP0068760)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/18:0/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0068762)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)/18:2(9Z,12Z)) (PathBank: SMP0068772)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/16:1(9Z)) (PathBank: SMP0068775)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/18:1(11Z)) (PathBank: SMP0068777)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/18:1(9Z)) (PathBank: SMP0068778)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0068780)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/16:0) (PathBank: SMP0068784)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0068785)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)/16:0) (PathBank: SMP0068788)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0068789)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0068794)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0074144)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/22:2(13Z,16Z)) (PathBank: SMP0074149)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/16:0/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0077504)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/18:0/18:0) (PathBank: SMP0077509)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/16:0) (PathBank: SMP0077522)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/18:0) (PathBank: SMP0077524)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0077531)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0077539)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/22:1(13Z)) (PathBank: SMP0089411)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/24:1(15Z)) (PathBank: SMP0089418)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/16:1(9Z)/16:1(9Z)) (PathBank: SMP0092779)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/18:1(11Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0092787)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)/16:0) (PathBank: SMP0092792)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0092794)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0092803)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0092811)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/16:0) (PathBank: SMP0092813)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0065395)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0065396)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0065403)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/16:0/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0068753)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/16:0/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0068755)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/16:1(9Z)/16:0) (PathBank: SMP0068757)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/18:1(9Z)) (PathBank: SMP0068769)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0068770)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)) (PathBank: SMP0068779)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0068786)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0068787)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0074151)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/22:5(7Z,10Z,13Z,16Z,19Z)) (PathBank: SMP0074152)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/24:0) (PathBank: SMP0074154)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/18:1(11Z)/18:1(9Z)) (PathBank: SMP0077513)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/22:6(4Z,7Z,10Z,13Z,16Z,19Z)/20:4(5Z,8Z,11Z,14Z)) (PathBank: SMP0077541)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/22:4(7Z,10Z,13Z,16Z)) (PathBank: SMP0089413)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0092802)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/16:0/22:5(4Z,7Z,10Z,13Z,16Z)) (PathBank: SMP0068754)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/18:1(11Z)/16:0) (PathBank: SMP0068763)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/16:0) (PathBank: SMP0068767)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/18:1(9Z)/18:1(11Z)) (PathBank: SMP0068768)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/18:1(11Z)/18:1(11Z)) (PathBank: SMP0092785)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0098660)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)/20:4(8Z,11Z,14Z,17Z)) (PathBank: SMP0098663)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/16:0) (PathBank: SMP0017996)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/18:0) (PathBank: SMP0017997)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:0) (PathBank: SMP0017998)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/14:1(9Z)) (PathBank: SMP0018001)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/16:1(9Z)) (PathBank: SMP0018002)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/18:1(11Z)) (PathBank: SMP0018003)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/18:1(9Z)) (PathBank: SMP0018004)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:1(11Z)) (PathBank: SMP0018005)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:3(5Z,8Z,11Z)) (PathBank: SMP0018006)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/18:2(9Z,12Z)) (PathBank: SMP0018009)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/18:3(6Z,9Z,12Z)) (PathBank: SMP0018010)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/18:3(9Z,12Z,15Z)) (PathBank: SMP0018014)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/18:4(6Z,9Z,12Z,15Z)) (PathBank: SMP0018015)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:2(11Z,14Z)) (PathBank: SMP0032813)
- De Novo Triacylglycerol Biosynthesis TG(16:0/20:4(5Z,8Z,11Z,14Z)/20:3(8Z,11Z,14Z)) (PathBank: SMP0032814)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083910)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083912)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/20:5(5Z,8Z,11Z,14Z,17Z)/20:5(5Z,8Z,11Z,14Z,17Z)) (PathBank: SMP0083913)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/22:0) (PathBank: SMP0098661)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(5Z,8Z,11Z,14Z)/22:1(13Z)) (PathBank: SMP0098662)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)/22:0) (PathBank: SMP0098664)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/20:4(8Z,11Z,14Z,17Z)/22:1(13Z)) (PathBank: SMP0098665)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/22:0/22:0) (PathBank: SMP0098666)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/22:0/22:1(13Z)) (PathBank: SMP0098667)
- Cardiolipin Biosynthesis CL(16:0/20:4(5Z,8Z,11Z,14Z)/22:1(13Z)/22:1(13Z)) (PathBank: SMP0098668)
|
|---|
| Role | Not Available |
|---|
| Physical Properties |
|---|
| State | Solid |
|---|
| Experimental Molecular Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Experimental Chromatographic Properties | Not Available |
|---|
| Predicted Molecular Properties | |
|---|
| Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times Underivatized| Chromatographic Method | Retention Time | Reference |
|---|
| Measured using a Waters Acquity ultraperformance liquid chromatography (UPLC) ethylene-bridged hybrid (BEH) C18 column (100 mm × 2.1 mm; 1.7 μmparticle diameter). Predicted by Afia on May 17, 2022. | 7.56 minutes | 32390414 | | Predicted by Siyang on May 30, 2022 | 34.4307 minutes | 33406817 | | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 1.94 minutes | 32390414 | | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 5024.5 seconds | 40023050 | | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 494.9 seconds | 40023050 | | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 332.3 seconds | 40023050 | | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 271.5 seconds | 40023050 | | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1105.1 seconds | 40023050 | | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 1824.0 seconds | 40023050 | | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 1198.2 seconds | 40023050 | | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 224.7 seconds | 40023050 | | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 3490.0 seconds | 40023050 | | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 1147.8 seconds | 40023050 | | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 2794.4 seconds | 40023050 | | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 1327.9 seconds | 40023050 | | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 720.9 seconds | 40023050 | | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 485.1 seconds | 40023050 | | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 807.8 seconds | 40023050 | | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 10.6 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedDerivatized| Derivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
|---|
| PA(16:0/20:4(5Z,8Z,11Z,14Z)),1TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C | 4935.7 | Semi standard non polar | 33892256 | | PA(16:0/20:4(5Z,8Z,11Z,14Z)),1TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C | 4388.5 | Standard non polar | 33892256 | | PA(16:0/20:4(5Z,8Z,11Z,14Z)),1TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C | 5614.1 | Standard polar | 33892256 | | PA(16:0/20:4(5Z,8Z,11Z,14Z)),2TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 4900.6 | Semi standard non polar | 33892256 | | PA(16:0/20:4(5Z,8Z,11Z,14Z)),2TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 4363.2 | Standard non polar | 33892256 | | PA(16:0/20:4(5Z,8Z,11Z,14Z)),2TMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O[Si](C)(C)C)O[Si](C)(C)C | 4880.7 | Standard polar | 33892256 | | PA(16:0/20:4(5Z,8Z,11Z,14Z)),1TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 5154.2 | Semi standard non polar | 33892256 | | PA(16:0/20:4(5Z,8Z,11Z,14Z)),1TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 4493.8 | Standard non polar | 33892256 | | PA(16:0/20:4(5Z,8Z,11Z,14Z)),1TBDMS,isomer #1 | CCCCC/C=C\C/C=C\C/C=C\C/C=C\CCCC(=O)O[C@H](COC(=O)CCCCCCCCCCCCCCC)COP(=O)(O)O[Si](C)(C)C(C)(C)C | 5594.0 | Standard polar | 33892256 |
|
|---|